WeVote
Log In

Bill

Bill

HB 2617

insurance; prostate cancer; cost sharing

57th Legislature - Second Regular Session Introduced by Walt Blackman

Arizona bill eliminates copays and deductibles for prostate cancer screening and treatment, increasing insurance coverage but potentially raising premiums.

DPA
0
WeVote Research Nonpartisan
Bill Summary · HB 2617

Legislative bill overview

HB 2617 would require health insurance plans in Arizona to cover prostate cancer screening and treatment without cost-sharing requirements (copayments, coinsurance, or deductibles). The bill specifically mandates that insurers provide these services at no out-of-pocket cost to patients, similar to preventive care requirements under the Affordable Care Act.

Why is this important

Prostate cancer is the most common cancer among American men, and early detection through screening can significantly improve treatment outcomes. Removing financial barriers to screening and treatment could increase utilization rates among at-risk populations and potentially catch cancers at earlier, more treatable stages. However, this also represents a new insurance mandate that could affect premium costs across the market.

Potential points of contention

  • Insurance cost implications: Mandating zero cost-sharing for prostate cancer services increases insurer expenses, which may be passed to employers and individual policyholders through higher premiums
  • Scope definition: The bill's language regarding what constitutes "prostate cancer screening and treatment" may be unclear, potentially creating disputes over coverage of borderline procedures or newer diagnostic tests
  • Equity concerns: Targeting one specific cancer type raises questions about why other cancers (breast, colorectal, pancreatic) don't receive similar mandated coverage, and whether this sets a precedent for disease-specific mandates

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.